CD276 and head and neck squamous cell carcinoma: B7-H3 (also known as CD276) is a member of the B7 ligand family, overexpressed in HNSCC, and provides an alternative immune checkpoint to therapeutically target alone or in combination with PD-1-targeted therapies.